57 related articles for article (PubMed ID: 30714683)
21. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.
Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S
BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523
[TBL] [Abstract][Full Text] [Related]
22. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY
Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116
[TBL] [Abstract][Full Text] [Related]
23. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
24. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
25. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
26. Marital status and survival in patients with rectal cancer: An analysis of the Surveillance, Epidemiology and End Results (SEER) database.
Wang X; Cao W; Zheng C; Hu W; Liu C
Cancer Epidemiol; 2018 Jun; 54():119-124. PubMed ID: 29727804
[TBL] [Abstract][Full Text] [Related]
27. Impact of age on survival of locoregional nasopharyngeal carcinoma: An analysis of the Surveillance, Epidemiology, and End Results program database, 2004-2013.
Huang SJ; Tang YY; Liu HM; Tan GX; Wang X; Zhang H; Yang F; Yang S
Clin Otolaryngol; 2018 Oct; 43(5):1209-1218. PubMed ID: 29688619
[TBL] [Abstract][Full Text] [Related]
28. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R; Wyrwicz L; Tiret E; Brown G; Rödel C; Cervantes A; Arnold D;
Ann Oncol; 2017 Jul; 28(suppl_4):iv22-iv40. PubMed ID: 28881920
[No Abstract] [Full Text] [Related]
29. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
30. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.
Uehara K; Nagino M
Surg Today; 2016 Feb; 46(2):161-8. PubMed ID: 26170102
[TBL] [Abstract][Full Text] [Related]
32. A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision.
Xiao WW; Zhang LN; You KY; Huang R; Yu X; Ding PR; Gao YH
J Cancer; 2015; 6(7):616-22. PubMed ID: 26078791
[TBL] [Abstract][Full Text] [Related]
33. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
[TBL] [Abstract][Full Text] [Related]
34. Association of marital status and colorectal cancer screening participation in the USA.
El-Haddad B; Dong F; Kallail KJ; Hines RB; Ablah E
Colorectal Dis; 2015 May; 17(5):O108-14. PubMed ID: 25704636
[TBL] [Abstract][Full Text] [Related]
35. In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer.
Wu JX; Wang Y; Chen N; Chen LC; Bai PG; Pan JJ
Radiat Oncol; 2014 Jul; 9():159. PubMed ID: 25052511
[TBL] [Abstract][Full Text] [Related]
36. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
[TBL] [Abstract][Full Text] [Related]
37. Marital status and survival in patients with cancer.
Aizer AA; Chen MH; McCarthy EP; Mendu ML; Koo S; Wilhite TJ; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Hu JC; Nguyen PL
J Clin Oncol; 2013 Nov; 31(31):3869-76. PubMed ID: 24062405
[TBL] [Abstract][Full Text] [Related]
38. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization.
Budczies J; Klauschen F; Sinn BV; Győrffy B; Schmitt WD; Darb-Esfahani S; Denkert C
PLoS One; 2012; 7(12):e51862. PubMed ID: 23251644
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of unselected patients with pathologic T3N0 rectal cancer.
Kennecke H; Lim H; Woods R; McGahan CE; Hay J; Raval MJ; Johal B
Radiother Oncol; 2012 Nov; 105(2):214-9. PubMed ID: 23200410
[TBL] [Abstract][Full Text] [Related]
40. T3N0 rectal cancer: radiation for all?
Wo JY; Mamon HJ; Ryan DP; Hong TS
Semin Radiat Oncol; 2011 Jul; 21(3):212-9. PubMed ID: 21645866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
